Jommi, C., and R. Ravasio. “The Value of Obinutuzumab for Untreated Advanced Follicular Lymphoma: An Assessment Based on Multicriteria Decision Analysis (MCDA)”. AboutOpen, vol. 6, no. 1, Nov. 2019, pp. 78-85, doi:10.33393/abtpn.2019.302.